User contributions for Palmdoc
From OncoWiki
Jump to navigationJump to search
7 February 2012
- 02:1802:18, 7 February 2012 diff hist 0 m FCM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m FC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Ewing’s sarcoma and primitive neuroectodermal tumor of bone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Etoposide + Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Esophageal Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Escalated BEACOPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Erlotinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Endometrial Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EVAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EVA 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ESHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EPOCH 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EPIC 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ECF + surgery + ECF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ECF 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EBVMm 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m EAPLG 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Doxorubicin + Bleomycin + Vinblastine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Doxorubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel + Estramustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexamethosone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexamethasone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dexa-BEAM 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Decitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DaunoXome 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dasatinib 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dactinomycin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dacarbazine + Cisplatin + Carmustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Dacarbazine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DVD 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DT-PACE 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DHAX 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DHAP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m DAT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cytotoxic Regimens 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cyclophosphamide Bortezomib Dexamethasone 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cyclophosphamide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Current events 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Colon Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Clofarabine, cyclophosphamide and etoposide 1 revision
- 02:1802:18, 7 February 2012 diff hist 0 m Cladribine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Topotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Irinotecan + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Gemcitabine + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide or Vinorelbine or Vinblastine or Vindesine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide + Bleomycin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Epirubicin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Epirubicin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + Capecitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + 5-FU + RT 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin + 5-FU 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cisplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chronic Myelogenous Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chronic Lymphocytic Leukemia 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chlorambucil + Prednisone 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Chlorambucil 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m ChlVPP 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cetuximab + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cetuximab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Cervical Cancer 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carmustine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carcinoid Tumors, Gastrointestinal 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Vinorelbine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Pemetrexed 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel + Bevacizumab 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Paclitaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Irinotecan 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Gemcitabine 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Etoposide 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin + Docetaxel 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Carboplatin 1 revision current
- 02:1802:18, 7 February 2012 diff hist 0 m Capecitabine + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Capecitabine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CapIri 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Cancer treatment information 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m CVP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CVD + IL-2 + IFN 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CVD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m COPP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CODOX-M/IVAC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CNOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CMV 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CMF 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CLAG 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CIM 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOP-14 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CHOEP-14 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CFAR 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CEP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CEOP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CBI 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CB 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 9710 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 9111 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CALGB 8811 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m CAF 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Breast Cancer 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Brain Tumors Adult 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bortezomib 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bonn protocol 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bladder Cancer 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bile Duct Cancer Extrahepatic 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bicalutamide 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BiRD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab + IFN 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab + Erlotinib 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bevacizumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bendamustine + Rituximab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Bendamustine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BFM B-Cell 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BFM- 95 (German Protocol) 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m BEP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Azacitidine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Arsenic Trioxide for relapsed APML 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Arsenic Trioxide for APML, new cases 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Anal Carcinoma 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Amrubicin 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Alemtuzumab + Fludarabine 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Alemtuzumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Adriamycin + Cisplatin + Paclitaxel 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Adriamycin + Cisplatin 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Myeloid Leukemia,Adult 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Lymphoblastic Leukemia, Pediatric 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m Acute Lymphoblastic Leukemia, Adult 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ATRA plus As203 1 revision
- 02:1702:17, 7 February 2012 diff hist 0 m ASHAP 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AIDA-PETHEMA Group 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AI 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ADOC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ADE 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m AC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ABVD 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m ABDIC 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m A-C-T 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU MitomycinC Radiation Therapy Wayne State Regimen 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU MitomycinC Radiation Therapy EORTC Regimen 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Mitomycin + Dipyridamole 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Irinotecan 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV + Bevacizumab 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + LV 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + Vinblastine + RT + Surgery 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + RT + Surgery 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + RT 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin + Docetaxel 1 revision current
- 02:1702:17, 7 February 2012 diff hist 0 m 5-FU + Cisplatin 1 revision current
- 02:1702:17, 7 February 2012 diff hist +162 Main Page →Getting started
28 November 2011
- 22:1722:17, 28 November 2011 diff hist +661 Nm Multiple Myeloma And Plasma Cell Dyscrasias →Bortezomib regimens
19 November 2011
- 01:4201:42, 19 November 2011 diff hist +1,539 N SMILE →References
19 September 2011
- 02:0902:09, 19 September 2011 diff hist +3,408 N Bonn protocol →References
15 September 2011
- 12:1412:14, 15 September 2011 diff hist +1,808 N Cyclophosphamide Bortezomib Dexamethasone New page: == Regimen == Bortezomib 1.3 mg/m(2) intravenously on days 1, 4, 8 and 11 Cyclophosphamide 300 mg/m(2) orally on days 1, 8, 15 and 22 Dexamethasone 40 mg orally on days 1-4, 9-12 and 1...
10 September 2011
- 23:4523:45, 10 September 2011 diff hist +2,924 Nm DT-PACE →Reference
7 September 2011
- 02:2802:28, 7 September 2011 diff hist +584 N Rituximab, Bendamustine, Bortezomib New page: ==Regimen== Bortezomib administered intravenously (IV) at a dose of 1.6 mg/m2 on days 1, 8, 15, and 22, cycles one to five; Bendamustine 50, 70, or 90 mg/m2 IV over a 60-minute infusio...
- 02:2302:23, 7 September 2011 diff hist +1,405 N Lymphoma Non-Hodgkin's, Adult →Indolent NHL
1 September 2011
- 04:4704:47, 1 September 2011 diff hist +3,968 N CFAR →References
- 04:4504:45, 1 September 2011 diff hist +834 N Chronic Lymphocytic Leukemia →Single agents
- 04:4304:43, 1 September 2011 diff hist +837 N Bendamustine →Indolent Non-Hodgkin's Lymphoma
13 July 2011
- 09:5509:55, 13 July 2011 diff hist +1,156 Nm BFM B-Cell →Block B
19 April 2011
- 05:5405:54, 19 April 2011 diff hist +699 N Clofarabine, cyclophosphamide and etoposide New page: == Regimen == Clofarabine 40 mg/m2 over 2 h IVI day 1-5 Cyclophosphamide 400 mg/m2 over 1 h day 1-5 Etooside 150 mg/m2 over 2 hr day 1-5 == Supportive == Prophylactic steroids were gi...
- 05:4505:45, 19 April 2011 diff hist +79 Nm Acute Lymphoblastic Leukemia, Pediatric →Relapse
5 April 2011
- 06:1706:17, 5 April 2011 diff hist +721 Nm Plerixafor and G-CSF →Regimen
- 06:1406:14, 5 April 2011 diff hist +169 N Stem Cell Transplantation →Mobilization Protocols
- 03:1403:14, 5 April 2011 diff hist +521 N GEM-Vinorelbine-Pred No edit summary
16 February 2011
- 03:1603:16, 16 February 2011 diff hist +2,063 N Main Page Editors added
29 December 2010
- 22:4522:45, 29 December 2010 diff hist +674 Nm Mitoxantrone + Prednisone Reverted edits by Emrick586899 (Talk); changed back to last version by Dobbs
13 December 2010
- 20:2320:23, 13 December 2010 diff hist +2,257 Nm Capecitabine Reverted edits by Alexander41972 (Talk); changed back to last version by Palmdoc
- 20:2120:21, 13 December 2010 diff hist +1,199 Nm Etoposide Reverted edits by Oswald569191 (Talk); changed back to last version by Palmdoc
22 July 2010
- 22:2822:28, 22 July 2010 diff hist +1,957 N BiRD →Reference
19 July 2010
- 07:4607:46, 19 July 2010 diff hist +1,954 Nm Bendamustine + Rituximab No edit summary
- 02:3902:39, 19 July 2010 diff hist +1,123 N PAD →Reference
- 02:2702:27, 19 July 2010 diff hist +1,402 N Alemtuzumab →[[Chronic_Lymphocytic_Leukemia|Chronic lymphocytic leukemia]]
3 May 2008
- 01:3901:39, 3 May 2008 diff hist +415 Nm Temozolomide + Thalidomide →Indication
5 December 2007
- 03:0303:03, 5 December 2007 diff hist +378 Nm Nasopharyngeal Cancer No edit summary
24 September 2007
- 13:5813:58, 24 September 2007 diff hist +770 N ABDIC No edit summary
- 10:3510:35, 24 September 2007 diff hist +481 N Lymphoma Hodgkin's, Adult No edit summary
7 September 2007
- 04:4304:43, 7 September 2007 diff hist +706 Nm GVD →Regimen
4 September 2007
- 08:3908:39, 4 September 2007 diff hist +3,932 N HyperCVADHDMTX-AraC →Hyper-CVAD
26 August 2007
- 23:1523:15, 26 August 2007 diff hist +10 N Test spam No edit summary
24 August 2007
- 23:3223:32, 24 August 2007 diff hist +546 Nm Guidelines for contributors No edit summary
17 August 2007
- 21:4121:41, 17 August 2007 diff hist +587 Nm TIP →Indication
- 09:0009:00, 17 August 2007 diff hist +2,599 Nm 5-FU + LV →Hepatocellular Carcinoma
15 August 2007
- 08:2208:22, 15 August 2007 diff hist +1,587 N CODOX-M/IVAC →[[Lymphoma_Non-Hodgkin%27s%2C_Adult|Non-Hodgkin's Lymphoma]]
10 August 2007
- 01:5901:59, 10 August 2007 diff hist +1,119 Nm Decitabine →Myelodysplastic syndrome
- 01:5801:58, 10 August 2007 diff hist +1,081 Nm Carmustine →Indications
- 01:5701:57, 10 August 2007 diff hist +1,772 Nm Bortezomib →[Lymphoma_Non-Hodgkin%27s%2C_Adult#Mantle_Cell_Lymphoma|Mantle Cell Lymphoma]]
- 01:5501:55, 10 August 2007 diff hist +1,275 Nm Azacitidine →Indications
9 August 2007
- 07:1307:13, 9 August 2007 diff hist +1,307 Nm Breast Cancer →Chemotherapy
- 03:3203:32, 9 August 2007 diff hist +446 Nm Endometrial Cancer No edit summary
- 03:2203:22, 9 August 2007 diff hist +1,244 Nm 5-FU + Cisplatin →Esophageal Cancer
- 03:1703:17, 9 August 2007 diff hist +1,635 Nm R-CHOP →Regimen
- 03:1503:15, 9 August 2007 diff hist +231 Nm Hairy Cell Leukemia →Single agent
- 03:1203:12, 9 August 2007 diff hist +2,824 N Cladribine No edit summary
- 03:0903:09, 9 August 2007 diff hist +1,359 Nm Fludarabine →[[Chronic_Lymphocytic_Leukemia|Chronic Lymphocytic Leukemia]]
8 August 2007
- 06:0706:07, 8 August 2007 diff hist +1,689 Nm PCV →References
- 05:5705:57, 8 August 2007 diff hist +429 Nm Temozolomide + RT →Anaplastic astrocytoma and glioblastoma
- 01:4201:42, 8 August 2007 diff hist +1,565 Nm Rituximab →Indications
- 01:2701:27, 8 August 2007 diff hist +576 Nm Cytotoxic Regimens →External Links
- 01:2401:24, 8 August 2007 diff hist +483 Nm Cyclophosphamide →[Lymphoma_Non-Hodgkin%27s%2C_Adult#Indolent_NHL|Indolent NHL]]
- 01:2201:22, 8 August 2007 diff hist +164 Nm Cancer treatment information No edit summary
7 August 2007
- 23:0923:09, 7 August 2007 diff hist +552 Nm Brain Tumors Adult No edit summary
- 06:4306:43, 7 August 2007 diff hist +721 N Gemcitabine + Cisplatin + Paclitaxel New page: == Indication == locally advanced or metatstatic bladder cancer *Gemcitabine (Gemzar) 1000 mg/m2 iv over 30-60 min d1, 8 *Cisplatin 70 mg/m2 iv d1 *Paclitaxel (Taxol) 80 mg/m2 iv d1, 8 Q3...
- 06:4106:41, 7 August 2007 diff hist +436 N Gemcitabine + Paclitaxel New page: == Indication == metastatic bladder cancer *Gemcitabine (Gemzar) 1000 mg/m2 iv d1, 8 and 15 *Paclitaxel (Taxol) 200 mg/m2 iv over 3 hrs d1 Q3w x 6 cycles === References === [http://www....
- 05:5105:51, 7 August 2007 diff hist +595 N LV5FU-P New page: == Regimen == *Leucovorin 200 mg/m2 iv over 2 hrs d1 *5-FU 400 mg/m2 iv bolus, followed by 600 mg/m2 iv over 22 hrs, d1 and 2 *Cisplatin 50 mg/m2 iv d2 Q2w == References == [http://annonc...
- 04:0304:03, 7 August 2007 diff hist +653 Nm Pentostatin No edit summary
- 03:2303:23, 7 August 2007 diff hist +2,597 Nm Imatinib No edit summary
- 02:5002:50, 7 August 2007 diff hist +720 N CMF New page: == Indication == Breast cancer == Regimen == *Cyclophosphamide 100 mg/m2/day PO on days 1-14 *Methotrexate 40 mg/m2 IV on days 1 and 8 *5-Fluorouracil 600 mg/m2 IV on days 1 and 8 Repeat...
- 02:4602:46, 7 August 2007 diff hist +1,311 N A-C-T New page: == Regimen == Patients with resected breast cancer involving four or more ipsilateral axillary lymph nodes were treated with nine cycles of chemotherapy, using 14-day intertreatment interv...
6 August 2007
- 23:3923:39, 6 August 2007 diff hist +3,248 N HyperCVAD →References
- 22:4122:41, 6 August 2007 diff hist +212 N CEOP New page: == Regimen == *Cyclophosphamide 750 mg/m2 IV on day 1 *Epirubicin 75 mg/m2 IV on day 1 *Vincristine 1.4 mg/m2 (Max 2mg) on day 1 *Prednisolone 100mg/m2 PO on days 1-5 Repeat cycle every 2...
- 22:3822:38, 6 August 2007 diff hist +316 N Current events New page: * 1. Registration is now open. You need to create a free login account in order to edit pages in Oncowiki. * 2. Call for Editors. If anyone is interested in being an Editor in Oncowiki, pl...
- 21:5321:53, 6 August 2007 diff hist +211 Nm Myelodysplastic Syndromes →Single agents
- 12:5112:51, 6 August 2007 diff hist +2,928 Nm LALA →Regimen
- 12:2212:22, 6 August 2007 diff hist +149 Nm Acute Lymphoblastic Leukemia, Adult No edit summary
- 12:1312:13, 6 August 2007 diff hist +1,809 N CALGB 8811 New page: == Regimen == Course I: Induction (4 wks) *Cyclophosphamide (Cytoxan) 1200 mg/m2 (800 mg/m2 if pts older than 60) iv d1 *Daunorubicine 45 mg/m2/d (30 mg/m2/d if pts older than 60) iv d1-3...
- 12:1012:10, 6 August 2007 diff hist +1,792 Nm Linker Regimen →CNS prophylaxis
- 12:0112:01, 6 August 2007 diff hist +567 N CLAG New page: == Indication == Relapsed or refractory acute myeloid leukemia == Regimen == *Cladribine 5 mg/m2/d iv over 2 hrs d1-5 *Cytarabine (Ara-C) 2 g/m2/d iv over 4 hrs d1-5 *Filgrastim (Neupogen...
- 11:5911:59, 6 August 2007 diff hist +520 Nm Acute Myeloid Leukemia,Adult →Salvage Regimens
- 11:5811:58, 6 August 2007 diff hist +957 Nm Gemtuzumab Ozogamicin No edit summary
- 09:3009:30, 6 August 2007 diff hist +2,650 N Total Therapy 2 New page: == Multiple Myeloma == === Induction === * Cycle 1, VAD Vincristine (0.5 mg/d x 4 d) CI; Adriamycin (10 mg/m2/d x 4 d) CI; Dexamethasone 40 mg PO d 1-4, 9-12, 17-20 * Cycle 2, DCE...
- 09:1509:15, 6 August 2007 diff hist +1,271 N Total Therapy 1 New page: == Multiple Myeloma == === Induction phase === *Cycles 1-3, VAD Vincristine (0.5 mg/d x 4 d) CI; Adriamycin (10 mg/m2/d x 4 d) CI; Dexamethasone 40 mg PO d 1-4, 9-12, 17-20 *Cycle 4...
- 08:5708:57, 6 August 2007 diff hist +555 Nm VMPT No edit summary
- 08:5308:53, 6 August 2007 diff hist +1,374 N Rev/Dex New page: == Multiple Myeloma == === Rev/Dex low dose === Lenalidomide (Revlimid) 25 mg po qd d1-21<br> Dexamethasone (Decadron) 40 mg po d1, 8, 15, 22<br> Q4w ==== References ==== [http://www.asc...
- 08:5008:50, 6 August 2007 diff hist +454 N DVD New page: == Multiple Myeloma == Pegylated liposomal doxorubicin (Doxil) 40 mg/m2 iv d1<br> Vincristine 2 mg iv d1<br> Dexamethasone (Decadron) 40 mg po qd d1-4<br> Q4w === References === [http://...
- 08:4808:48, 6 August 2007 diff hist +487 N VAD New page: == Multiple Myeloma == Vincristine 0.4 mg iv over 30 min qd d1-4<br> Doxorubicin (Adriamycin) 9 mg/m2 iv over 30 min qd d1-4<br> Dexamethasone (Decadron) 40 mg po qd d1-4, 9-12, 17-20<br>...
- 08:4608:46, 6 August 2007 diff hist +1,215 N MPT New page: == Multiple Myeloma == === Melphalan + Prednisone + Thalidomide regimen 1 === Melphalan (Alkeran) 0.25 mg/kg/d po d1-4 q6w x 12 cycles<br> Prednisone 2 mg/kg/d po d1-4 q6w x 12 cycles<br> ...
- 08:4308:43, 6 August 2007 diff hist +2,063 N Thal/Dex New page: == Multiple Myeloma == Thalidomide ((Thalomid) 100-200 mg po qd<br> Dexamethasone (Decadron) 40 mg po qd d1-4, 9-12, 17-20 for odd cycles and d1-4 only for even cycles q4w Thal-Dex was p...
- 08:3408:34, 6 August 2007 diff hist +680 Nm MP No edit summary
- 05:0305:03, 6 August 2007 diff hist +643 Nm Hematological Malignancies No edit summary
5 August 2007
- 23:4923:49, 5 August 2007 diff hist +962 N FC No edit summary
- 23:1123:11, 5 August 2007 diff hist +94 N Chronic Myelogenous Leukemia New page: == Single agents == Imatinib (Gleevec) Dasatinib (Sprycel) Nilotinib (Tasigna)
- 14:5914:59, 5 August 2007 diff hist +5,929 N BFM- 95 (German Protocol) →Regimen
- 14:5414:54, 5 August 2007 diff hist +1,536 Nm Arsenic Trioxide for relapsed APML No edit summary
- 14:4814:48, 5 August 2007 diff hist +643 N 5-FU MitomycinC Radiation Therapy EORTC Regimen New page: == Regimen == * 5-Flurouracil: 750mg/m2/day IV continuous infusion on days 1-5 and 29-33 * Mitomycin-C: 15mg/m2 IV on day 1 * Radiation therapy: 180 cGy/day over 5 week period (tota...
